Orchestra BioMed Holdings (OBIO) Invested Capital (2021 - 2026)

Orchestra BioMed Holdings (OBIO) posted quarterly Invested Capital of $9.6 million for Q3 2023.

Analysis

Orchestra BioMed Holdings (OBIO) Invested Capital (2021 - 2026) Analysis & Trends

Orchestra BioMed Holdings (OBIO) has reported Invested Capital for 1 consecutive years, with $9.6 million the latest figure, recorded in Q3 2023.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn	33.70 Bn
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn	-
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn	7.35 Bn
5	Revolution Medicines	44.33 Bn	44.33 Bn	-	-
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn	6.25 Bn
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn	-
8	Royalty Pharma	28.45 Bn	27.61 Bn	-	19.13 Bn
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	1.30 Bn
10	Orchestra BioMed Holdings	322.25 Mn	127.72 Mn	63,000.00	33.72 Mn

Historic Data

Download Data